GHRL and Anxiety: In addition, based on previous studies showing that psychological factors are closely related to the pathogenesis of FD [12,33,34], we will measure HADS as a secondary outcome to determine whether anxiety and depressive symptoms are improved after administration of investigational products and to examine the correlation with other outcomes such as TDS and ghrelin.